For the purpose of developing amino acid imbalance solution applicable to cancer treatment, we prepared seven kinds of amino acid imbalance solutions based on a 10% balanced amino acid solution and investigated the anti-tumor effects of each solution. The administration of valine-depleted amino acid solution for 8 days at a daily dose of 53 ml/rat (79.5 kcal/rat) resulted in the most significant inhibitory effects on the growth of hepatoma (AH109A) and mammary tumors (MRMT-1), the rate being 82.8% and 90.8%, respectively. Side effects observed were inhibition of increases in host body weight , weight loss of the spleen and thymus, loss of hair, and a decrease in the amounts of total plasma protein and albumin. When the daily dosage of valine-depleted amino acid solution was reduced to 40 ml/rat (58.3 kcal/rat), anti-tumor effects were still noticed , while side effects were abated. These findings indicate that side effects accompanying the use of this solution can be alleviated by controlling the ingredients of the solution as well as the amount administered. It is thus suggested that valine-depleted amino acid imbalance solution is a valuable tool in the treatment of cancer.
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amino acid imbalance; valine; isoleucine; total parenteral nutrition Attempts to inhibit tumor growth by the use of amino acid solution from which a certain essential amino acid has been removed (amino acid imbalance solution) have been carried out by many researchers (Drummond 1917; Skipper and Johnson 1958; Sugimura et al. 1959; Lorincz and Kuttner 1965; Theuer 1971) Since the administration of such imbalance solution was carried out orally or through the stomach in these studies, the amount of intake tended to decrease or dosage was inevitably limited, and therefore, it was almost impossible to maintain a good state of nutrition.
For this reason, it was quite difficult to determine whether anti-tumor effects obtained were induced by the poor state of et al. nutrition or by the amino acid imbalance solution administered.
Recent development of total parenteral nutrition (TPN) has facilitated high caloric intake and enabled precise nutritional control. With these improvements, researchers have begun to reconsider the application of amino acid imbalance solution to cancer treatment.
There have already been some reports (Omura et al. 1983 ) that favorable anti-tumor effects exceeding those of conventional therapy can be obtained by the combined use of amino acid imbalance solution and TPN. Unfortunately, however, there have been almost no studies to determine amino acids whose removal induces the most favorable anti-tumor effects. For the purpose of clarifying this question, we prepared seven kinds of imbalance solu tions, each lacking in one or two essential amino acids, and compared the antitumor effects of these solutions. In addition, we also examined the effect of such imbalance solution on the tumor host.
MATERIALS AND METHODS

Animals and tumors
Male Donryu rats (Nihon Rat Co., Urawa) and female Sprague-Dawley (SD) rats (Shizuoka Prefectural Experimental Animal Center, Hamamatsu), 6 weeks of age, were purchased. These rats were fed with commercial pellets (MF, Oriental Yeast Co., Ltd., Funabashi) and given water. Among these rats, those that showed a favorable increases in body weight ranging from 170 to 190 g were used for the experiment. 
Method of administration of amino acid imbalance solution
Three days prior to TPN catheter insertion, in the case of AH109A , or 7 days prior to the insertion, in the case of MRMT-1, a cutaneous flap was made on the back of each rat under Nembutal anesthesia by the method of Tashiro and Meng (1972) so that a harness could be placed for a long period ; the tumors were then transplanted subcutaneously to the right side of the backs of those rats. After fixation of the harness , TPN catheter insertion was conducted under etherization by Steiger's method (Steiger et al . 1972 ). After cannula- 
RESULTS
Anti-tumor effects of amino acid imbalance solution on AH109A subcutaneous tumor Table 2 indicates experimental results of anti-tumor effects ; seven kinds of amino acid imbalance solutions were divided into 4 experimental groups, each of the groups having a control group. As clearly shown in this table, the most remarkable inhibitory effect on tumor growth was found in the Val-depleted imbalance group (p<0.01).
On the other hand, during TPN, a marked inhibitory effect on the increase in host body weight was noted in the Val-depleted (p <0.01), Ile-depleted (p <0.01) and Trp-depleted (p <0.05) imbalance groups. Morbidity was especially high in the Thr(-) group, in which all the rats died of malnutrition during TPN, and thus it was confirmed that Thr(-) imbalance could not be used for clinical trials. As shown in Fig. 1 , daily changes in tuomr volume in the control group, the Val-depleted group, and the Phe plus Tyr-depleted group were examined during TPN. From the second day of TPN, significant growth inhibi tory effects (p <0.01) were noted in both the imbalance groups as compared with the control group ; however, a gradual increase in tumor volume was also recog nized in both the imbalance groups.
Effects of amino acid imbalance solution on MRMT -1 tumor-bearing rats in Administration I experiment With regards to anti-tumor effects, Table 3 indicates the experimental results for Val-depleted, Trp-depleted, Ile-depleted, and Met plus Cys-depleted groups , which were divided into three experimental groups with respective controls. As shown in Table 3 , the most considerable inhibitory effect on tumor growth was seen in the Val-depleted imbalance group (p <0.01) ; this was followed by the Although tumor growth appeared to be suppressed in the Met plus Cys-depleted imbalance group, it was not significant. During TPN, deaths were noticed in all imbalance groups. Fig. 2 shows daily changes of tumor volume during TPN in the control group, the Val-depleted imbalance group, and the Trp-depleted imbalance group. In the control group a daily increase in tumor volume was observed, whereas in the Val-depleted group tumor volume remained unchanged from the day following initiation of TPN; thus after the 5th day, the difference between the Val-depleted imbalance group and the control group was very marked (p <0.01). For 7 days after the initiation of TPN, the Trp-depleted imbalance group did not differ much from the control group in tumor volume, but on the 8th day a noticeable inhibi tory effect on tumor growth (p <0.01) was seen. Fig. 3 shows the changes in body weight of hosts of the control group, the Val-depleted imbalance group, and the Trp-depleted imbalance group. Although decreased on the first day of TPN, the body weight began to increase on the second day in each group. Compared with the control group, a rather inhibitory ten dency was noted in the Val-depleted imbalance group. This tendency was especially evident on the 4th, 5th, and 8th days after TPN was started (p <0.05). Fig. 4 shows the weight of the liver, kidneys, lungs, spleen, thymus and gastrocnemius of rats in each group. Although there were no marked differences in the weight of the liver between these groups, the weight of the kidneys was found to increase in Val-depleted (p <0.01), Trp-depleted (p <0.05), and Met plus Cys-depleted (p <0.01) imbalance groups. On the other hand, the weight of the lungs significantly decreased in Val-depleted, Ile-depleted, and Met plus Cysdepleted imbalance groups (p<0.01).
A considerable decrease in the weight of the spleen was noticed in Val-depleted and Ile-depleted imbalance groups. The weight of the thymus notably decreased in Val-depleted, lle-depleted, and Trp-depleted imbalance groups. The weight of the gastrocnemius also markedly decreased in the Ile-depleted imblalance group (p<0.01). Fig. 5 shows the effects of amino acid imbalance solution on plasma protein of MRMT-1 tumor bearing rats. Except for the Trp-depleted imbalance group, the content of total protein in each group tended to decrease, this decrease being especially significant in the Val-depleted imbalance group (p<0.01). A significant decrease in the amount of albumin was obvious in all imbalance groups (p<0.01). Effects of amino acid imbalance solution on MRMT -1 tumor-bearing rats in Administration II experiment Fig. 6 shows daily changes in tumor volume during TPN in the control group , the Val-depleted imbalance group, and the fully deficient amino acid group . In the Val-depleted imbalance group , tumor volume remained unchanged from the second day of TPN, and on the 8th day, a marked inhibitory effect was noted (p < 0.05). Considering in vivo amino acid metabolism, we initially examined the essential amino acids. With AH109A, the most significant antitumor effect was found to be brought about by Val-depleted and Ile-depleted imbalance solution (Table 2 To compare anti-tumor effects on the different types of cancer, we then examined MRMT-1 which is dependent on prolactin. The findings revealed that Val-depleted imbalance solution can induce considerable anti-tumor effects, much greater than those noted for AH109A (Table 3) . In this experiment, MRMT-1 completely cased to grow on the day following administration of imbalance solution (Fig. 2) . One reason for this surprising anti-tumor effect seems to be the inhibitory effect of Val-depleted imbalance solution on the productivity of prolactin, which is likely to participate in tumor growth. Although further clarification is needed, such a remarkable effect suggests that Val-depleted imbal-ante solution can have an anti-tumor effect on hormone dependent tumors.
In experiments using SD rats, death occurred in all imbalance groups, suggesting the difference in host sensitivity between SD rats and Donryu rats. With regard to the weight of main internal organs, significant differences were noticed in the liver, kidneys, lungs, and gastrocnemius between the control group and some of the amino acid imbalance groups. As for the weight of the spleen and thymus, however, a drastic decrease was noted in Val-depleted and Ile-depleted imbalance groups. This seems to imply the deterioration of immune function in the tumor host (Fig. 4) . The contents of plasma protein and albumin were likely to decrease in imbalance groups, a tendency which was significant especially in the Val-depleted imbalance group (Fig. 5) . This suggests that Val-depleted imbal ance solution has a greater inhibitory effect on protein synthesis as compared with other kinds of amino acid imbalance solution.
In the Administration I experiment, the dosage of amino acid imbalance solution was 68.5 kcal/rat/day.
Since death occurring during this experiment was thought to be due in part to such a high calorie dosage, we then reduced the dosage to 51.7 kcal/rat/day in Administration II. Weight gain for 8 days during TPN was 37,6±12.3 gin Administration I (Fig. 3) and 32.4±21.4 gin Administra tion II (Fig. 7) . The findings implied that this degree of calorie reduction does not much affect the hosts. In the Val-depleted imbalance group, however, weight gain was 16.5± 10.7 g for Administration I and 23.2±21.4 g for Adminis tration II, showing a tendency to increase. In Administration, none of the fatalities were noticed during TPN, while anti-tumor effects were noted as in the case of Administration I (Fig. 6) . It is thus evident that Val-depleted imbalance solution with a reduced dosage can maintain anti-tumor effects while relieving side effects in tumor hosts. In the fully deficient amino acid group, neither anti-tumor effects (Fig. 6 ) nor increase in host body weight (Fig. 7) were observed ; these facts are similar to those reported by Steiger (Steiger et al. 1975 ). These findings imply that tumor growth is not directly related to calorie dosage but rather depends on the kind of amino acids administred.
A common problem in treating cancer with amino acid imbalance solution is the occurrence of side effects. Obtained results, however, suggest that such problems can be alleviated by controlling the ingredients and the amount of solution administered. Among the imbalance solutions tested, Val-depleted im balance solution was shown to have the most significant anti-tumor effects. Its efficacy seems to outweigh the side effects which can be alleviated with TPN. It is thus expected that Val-depleted imbalance solution will lead to a new avenue of cancer treatment.
